No Picture
Business News

‘Lemon’ or not, Trump stuck with Phase 1 China trade deal for now

U.S. President Donald Trump has little choice but to stick with his Phase 1 China trade deal for now despite his anger at Beijing over the coronavirus pandemic, new Hong Kong security rules, and dwindling hopes China can meet U.S. goods purchase targets, people familiar with his administration’s deliberations say.

…read more […]

No Picture
Trading Ideas

Modi Magic Absent in New Term as India Stocks Erase $543 Billion

(Bloomberg) — Follow Bloomberg on LINE messenger for all the business news and analysis you need.The Indian stock market’s honeymoon with Prime Minister Narendra Modi’s government is under strain.In the first year of Modi’s second term, India has erased more shareholder wealth than any other country on the planet, except Brexit-swayed Britain. That contrasts with his first term of five years, when his reputation as an economic reformer fueled an increase of almost 50% in equity market capitalization.Today, the economy as well as equity values are sinking. Economic growth slumped to an 11-year low even before the full onset of …read more […]

No Picture
Trading Ideas

Hedge Funds Cashing Out Of Crestwood Equity Partners LP (CEQP)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […] …read more […]

No Picture
Trading Ideas

Pfizer declines about 8% after setback to breast cancer treatment

The treatment, Ibrance, was being tested along with the standard of care for early breast cancer in men and women, against standard of care alone, the company said on Friday. The study was broadly seen to have a high probability of success readout, but the early failure represents a meaningful setback for Pfizer, JP Morgan analysts said in a note, cutting its price target on the stock by $1 to $37. …read more […]